Chronic News and Research

RSS

FDA approves Watson Pharmaceuticals' generic version of VALTREX tablets

Watson Pharmaceuticals, Inc., today announced that its subsidiary, Watson Laboratories, Inc., has received approval from the United States Food and Drug Administration on its Abbreviated New Drug Application for Valacyclovir Hydrochloride tablets, USP, in the 500 and 1000 mg strengths, the generic equivalent to GlaxoSmithKline, LLC's VALTREX tablets.

25 May 2010

STOP Obesity Alliance researchers receive $250,000 donation to research on health impact of obesity

The research team of The George Washington University School of Public Health and Health Services' Department of Health Policy's Strategies to Overcome and Prevent Obesity Alliance received a $250,000 donation from Allergan, Inc. to support public health, policy analysis and research about the economic and health impact of obesity and related chronic diseases.

25 May 2010

Beta-blocker medications provide new hope for patients with COPD: Study

Patients with chronic obstructive pulmonary disease may have fewer respiratory flare-ups and longer survival if they take beta-blocker medications, according to a report in the May 24 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

25 May 2010

66% of patients with schizophrenia have extreme trust in their psychiatrists: New survey

According to a new survey sponsored by Janssen, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc, 80 percent of patients with schizophrenia, a chronic, severe and disabling brain disorder, say their psychiatrists do well or very well in treating them with courtesy and respect. This positive relationship is particularly important in treating schizophrenia as patients and psychiatrists must work closely together to determine appropriate treatment plans that will help patients manage their symptoms and reduce their risk of relapse.

24 May 2010

NormOxys raises $17.5M in Series B financing round

NormOxys, Inc., a biotechnology company developing a novel class of small molecule drugs which enhance the body's ability to deliver oxygen to diseased tissues, today announced that it has raised $17.5 million in a Series B financing round. The financing was led by a new investor, Care Capital, LLC, with participation from existing venture investor Index Ventures.

24 May 2010

Salix Pharmaceuticals announces availability of Xifaxan tablets for reducing risk of overt HE recurrence

Salix Pharmaceuticals, Ltd. today announced the availability of Xifaxan (rifaximin) 550 mg tablets for the reduction in risk of overt hepatic encephalopathy recurrence in patients 18 years of age or older. Those HE patients may now fill their Xifaxan 550 mg prescriptions in U.S. pharmacies and should speak with their doctors about this important treatment option.

24 May 2010

Phase 1 clinical trial of OXY111A initiated

NormOxys Inc., a biotechnology company developing a novel class of small molecule drugs which enhance the body's ability to deliver oxygen to diseased tissues, today announced that it has initiated a Phase 1 clinical trial of OXY111A, a novel allosteric modulator of affinity of oxygen to hemoglobin. NormOxys plans to initially develop this compound as a treatment for chronic heart failure and cancer indications.

24 May 2010

Delegates at the World Health Assembly adopt resolutions on variety of global health issues

The 63rd World Health Assembly, which brought together Health Ministers and senior health officials from the World Health Organization's Member States, concluded business and closed Friday evening.

24 May 2010

New therapies can turn cancer into chronic disease

Two new studies suggest that the prolonged use of cancer drugs helped stunt the progress of the disease, a shift from the scheduled courses of treatment typically delivered to patients, The Wall Street Journal reports.

24 May 2010

Researchers develop new therapy for psychological treatment of patients suffering from fibromyalgia

Researchers of the Labpsictec at the Universitat Jaume I of Castellon and the LahHuman Group at the Universidad Politecnica of Valencia and the University of Valencia have developed a new therapy based on the use of mobile devices and virtual reality for the psychological treatment of patients suffering from fibromyalgia.

24 May 2010

At-home blood pressure monitors help patients manage their high blood pressure: Research

The use of at-home blood pressure monitors and web-based reporting tools that connect clinicians and patients via the Internet appears to significantly improve patients' ability to manage their high blood pressure to healthy levels, according to research from Kaiser Permanente.

24 May 2010

Universally applicable definitions of malnutrition

New and universally applicable definitions of malnutrition are published in the current issue of Clinical Nutrition. These are the result of a major international collaboration that has been endorsed by ESPEN and the American nutrition society ASPEN.

24 May 2010

Research aims to describe women's experience of living with MS

The women who I asked would like to have time and opportunity to express grief and vulnerability in contact with health services. They also expect a response based on their individual situation and needs, "said Malin Olsson, Ph.D. at Luleå University of Technology.

21 May 2010

African-Americans, Hispanics less likely to meet MTM eligibility requirements: Study

Medicare's Part D prescription medication management program, also known as Medication Therapy Management, could be off limits to some of the patients who need it most — older African-Americans and Hispanics — a new study finds.

21 May 2010

CTT's Calmare Pain Therapy Treatment decreases pain associated with CIPN

Competitive Technologies, Inc. today announced the issuance of an abstract from a study which has shown the successful treatment of patients suffering from pain associated with chemotherapy-induced peripheral neuropathy using CTT's Calmare Pain Therapy Treatment.

21 May 2010

New data on ARIAD's AP24534 and ridaforolimus accepted for presentation at ASCO 2010

ARIAD Pharmaceuticals, Inc. today announced that new data on AP24534, its investigational pan-BCR-ABL inhibitor, and ridaforolimus, its investigational mTOR inhibitor being developed by Merck, Sharpe & Dohme Corp., have been accepted for presentation at the American Society of Clinical Oncology (ASCO) Annual Meeting.

21 May 2010

Tai Chi may help reduce stress, anxiety and depression

Tai Chi, a low impact martial art, has been associated with reduced stress, anxiety and depression, and enhanced mood, in both healthy people and those with chronic conditions.

21 May 2010

Data on serum DNA blood tests for early detection of cancer to be presented at ASCO 2010

Chronix Biomedical today reported a summary of data supporting the utility of its serum DNA blood tests for the early and accurate detection of breast cancer and prostate cancer. The unique testing algorithms developed by Chronix detected and correctly identified DNA fragments in the blood from dying (apoptotic) cancer cells with 92% sensitivity and 100% specificity in both prostate cancer and breast cancer.

21 May 2010

European researchers define research priorities in biogerontology

The quality of the medical care for geriatric patients is a major investment for society and must imperatively be a research priority in Europe. This is why 50 European researchers, met on May 17 - 19 in Brussels, to define the research priorities in the field of biogerontology for the next 10 to 15 years.

21 May 2010

Study explores genetic imbalances that give rise to childhood brain tumors

The most comprehensive analysis yet of the genetic imbalances at the heart of childhood brain tumors known as high-grade gliomas (HGGs) identified a cancer gene that is unusually active in some tumors and is now the focus of a St. Jude Children's Research Hospital clinical trial.

21 May 2010

Chronic News and Research

FDA approves Watson Pharmaceuticals' generic version of VALTREX tablets

STOP Obesity Alliance researchers receive $250,000 donation to research on health impact of obesity

Beta-blocker medications provide new hope for patients with COPD: Study

66% of patients with schizophrenia have extreme trust in their psychiatrists: New survey

NormOxys raises $17.5M in Series B financing round

Salix Pharmaceuticals announces availability of Xifaxan tablets for reducing risk of overt HE recurrence

Phase 1 clinical trial of OXY111A initiated

Delegates at the World Health Assembly adopt resolutions on variety of global health issues

New therapies can turn cancer into chronic disease

Researchers develop new therapy for psychological treatment of patients suffering from fibromyalgia

At-home blood pressure monitors help patients manage their high blood pressure: Research

Universally applicable definitions of malnutrition

Research aims to describe women's experience of living with MS

African-Americans, Hispanics less likely to meet MTM eligibility requirements: Study

CTT's Calmare Pain Therapy Treatment decreases pain associated with CIPN

New data on ARIAD's AP24534 and ridaforolimus accepted for presentation at ASCO 2010

Tai Chi may help reduce stress, anxiety and depression

Data on serum DNA blood tests for early detection of cancer to be presented at ASCO 2010

European researchers define research priorities in biogerontology

Study explores genetic imbalances that give rise to childhood brain tumors

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News